Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
OTC Markets
23:27:10 10/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.83M 1.72M 1.57M 2.94M 201M 2.95M 20.36M 7.9M 103M 7.99M 7.82M 332M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.8M 5.46M 4.99M 9.33M 637M 9.35M 64.51M 25.03M 327M 25.32M 24.77M 1.05B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | +9,900.00% | -.--% | 2.13K | ||
| +2.31% | +1.58% | -6.72% | +29.78% | 3.47B | ||
| +2.87% | +7.72% | +45.66% | +1,467.06% | 3.08B | ||
| +9.99% | +12.71% | +61.42% | +490.10% | 2.73B | ||
| +2.01% | -0.82% | -28.86% | -16.03% | 1.78B | ||
| +1.56% | -1.02% | +124.14% | +490.91% | 1.51B | ||
| +0.88% | -0.58% | +3.78% | +15.46% | 577M | ||
| +1.78% | +1.33% | +25.82% | +37.95% | 349M | ||
| +1.40% | +2.84% | +42.16% | +49.48% | 205M | ||
| +2.27% | +2.27% | +29.81% | +68.75% | 117M | ||
| Average | +2.51% | +2.83% | +1,019.72% | +263.35% | 1.38B | |
| Weighted average by Cap. | +3.74% | +4.07% | +32.12% | +485.70% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.18M 13.35M 12.19M 22.81M 1.56B 22.87M 158M 61.2M 799M 61.9M 60.55M 2.57B | 14.01M 12.06M 11.34M 10.36M 19.39M 1.32B 19.44M 134M 52.02M 679M 52.62M 51.47M 2.19B |
| Net income | -4.29M -3.69M -3.47M -3.17M -5.94M -405M -5.95M -41.06M -15.93M -208M -16.12M -15.77M -670M | -7.61M -6.55M -6.16M -5.63M -10.53M -718M -10.55M -72.79M -28.24M -369M -28.57M -27.95M -1.19B |
| Net Debt | 3.04M 2.62M 2.46M 2.25M 4.21M 287M 4.22M 29.11M 11.3M 147M 11.43M 11.18M 475M | 4.62M 3.97M 3.74M 3.41M 6.38M 436M 6.4M 44.15M 17.13M 224M 17.33M 16.95M 720M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















